Progress in gastric cancer surgery in Japan and its limits of radicality

World Journal of Surgery - Tập 11 Số 4 - Trang 418-425 - 1987
Keiichi Maruyama1, Kan Okabayashi2, Taira Kinoshita2
1Gastric Surgery Division National Cancer Center Hospital 5‐1‐1, Tsukiji, Chuo‐ku 104 Tokyo Japan
2Gastric Surgery Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, 104, Tokyo, Japan

Tóm tắt

Abstract

Radical surgery of gastric cancer has become more widely utilized in Japan. Topics explored in gastric cancer surgery include the extended lymph node dissection guided by the node staining method with India ink, left upper abdominal organs exenteration for advanced cancer of the upper stomach, and pancreaticoduodenectomy for advanced cancer of the lower stomach. Through the progress of surgical treatment as well as that of the early detection system, the treatment results have been improved. Using the data from nationwide registrations (5,706 and 11,845 cases) and those from the National Cancer Center Hospital (3,176 cases), the 5‐year survival rate of total primary resected cases was 44.3% in the first period (1963–1966), 56.3% in the second period (1969–1973), and 61.6% in the third period (1971–1985). Between the first and the third period, the 5‐year survival rate of patients with stage 2 cancer increased from 60.6% to 71.7%, and that of stage 3 increased from 32.7% to 44.3%; however, the limits of radical surgery were also clarified, especially in patients with peritoneal dissemination, liver metastasis, distant lymph node metastasis, and diffusely infiltrating carcinoma (Borrmann type 4). For such patients, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, and hyperthermia should possibly be employed in hopes of improving treatment result.

Từ khóa


Tài liệu tham khảo

Maruyama K., 1987, Standard Treatment of Gastric Cancer (UICC manual)

10.5833/jjgs.12.961

10.5833/jjgs.18.912

Ohashi I., 1986, Gastric Cancer Surgery (The Latest Therapy), vol. 3, 344

Maruyama K., 1986, Gastric Cancer Surgery (The Latest Therapy), vol. 3, 358

Nishi M., 1970, Pancreaticoduodenectomy against gastric cancer, Rinsho‐geka, 32, 887

Miyazaki I., 1986, Gastric Cancer Surgery (The Latest Therapy), vol. 3, 376

Nimura Y., 1986, Gastric Cancer Surgery (The Latest Therapy), vol. 3, 384

10.1007/BF02468883

Japanese Research Society for Gastric Cancer National Cancer Center:The Report of Treatment Results of Stomach Carcinoma in Japan (1963–1966) Tokyo National Cancer Center 1977.

Japanese Research Society for Gastric Cancer National Cancer Center:The Report of Treatment Results of Stomach Carcinoma in Japan (1969–1973) Tokyo National Cancer Center 1983.

Koga S., 1986, Gastric Cancer Surgery (The Latest Therapy), vol. 3, 525

Takahashi T., 1984, Intraabdominal administration of mitomycin C adsorbed on activated carbon for management of carcinomatous peritonitis, Jpn. J. Cancer Chemother., 11, 1550

Okuyama K., 1984, Clinical studies on effective treatment for gastric cancer patients with synchronous hepatic metastasis, J. Jpn. Soc. Cancer Ther., 19, 763

Kitaoka K., 1985, Combination therapy of mitomycin C, Tegafur and Nolvadex for schirrous gastric cancer, Shokaki‐geka Semin., 21, 50

Thông tin
Thông tin xuất bản

World Journal of Surgery

Tập 11 Số 4

418-425

Thông tin tác giả